Skip to content
Disclosery

MORGAN STANLEY: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MORGAN STANLEY on GSK, newest first. How the timeline and the estimate are built.

MORGAN STANLEY held 7,657,562 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,657,562 shares
    Change vs previous 13F -3,373,089 shares

    0.02% of the 13F portfolio, value $401,409,572.

    13F-HR 0000895421-26-000243 filed by MORGAN STANLEY
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 11,030,651 shares
    Change vs previous 13F +5,201,988 shares

    0.04% of the 13F portfolio, value $608,781,788.

    13F-HR 0000895421-26-000183 filed by MORGAN STANLEY
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F/A 5,828,663 shares
    Change vs previous 13F +879,435 shares

    0.02% of the 13F portfolio, value $285,837,786.

    13F-HR/A 0000895421-26-000187 filed by MORGAN STANLEY
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F/A 4,949,228 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $213,608,798.

    13F-HR/A 0000895421-26-000186 filed by MORGAN STANLEY
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).